Properties

  • Title:
    Printed medical solution
  • Technology profile
  • OFFER from Italy, reference: TOIT20170207001, valid from 07-02-2017 untill 05-09-2020
  • Created:
    11 september 2018
  • Updated:
    6 september 2020

General information

  • Reference:
    TOIT20170207001
  • Profile type
    Technology offer
  • Country of origin:
    Italy
  • Deleted
    Ja
  • Status:
    Delete
  • Start date:
    7 februari 2017
  • End date:
    5 september 2020

Technologic information profile

  • Title:
    Printed medical solution
  • Description:
    An Italian startup, specialized in bioprinting activity, develops 3D-bioprinters targeting human tissue repair and regeneration with dermatology, orthopedic, dental and osteo-articular applications. The startup know-how is a combination of pharmaceutical technology, mechanical engineering, biomaterials, biotechnology and analytical chemistry.
    The startup is proposing an innovative 3D printed tissue repair therapies, suitable to help the healing of chronic wounds, through bio-absorbable hydrogels based on chitosan dressing.
    The R&D area of the startup is working on the development of new materials (bio-inks), like stimuli-sensitive bio compatible and bioresorbable polymers. These bio-inks are dispensed from the 3D printer in a layer-by-layer approach to build finely tuned scaffolds (materials engineered to cause cellular interactions to form new functional tissues) in a variety of advanced designs, presenting high improved cell-compatibility.
    Experimental models (in vivo experiments), performed and coordinated by the startup’s experienced staff, are used for investigating the tissue repair and tissue regeneration properties of the developed products.
    The startup is looking for industrial partners working in the health-care area (pharmaceutical or biomedical companies) interested in the development of innovative medical devices in the regenerative medicine field.
    The startup wants to pursue the industrialization process of its products, throughout a manufacturing agreement, but it is also open to financial or license agreement to support the product industrialization.
  • Technologie keywords
    • Medcine, Human Health
  • Activity codes
    • Other human health activities
  • Languages
    • English
    • French
  • Exploitations
    • Other
  • Sector groups
    • Bio Chem Tech

More information

  • Plus Value:
    The 3D printed product of the company is able to:
    - address a controlled tissue repair process;
    - present controlled biodegradation and transpiration;
    - distribute and release drugs in a controlled way;
    - avoid the use of toxic materials.
    Moreover, the dressing:
    - has high water content (customizable);
    - has effective sponge effect on heavily exuding wounds;
    - is easy to apply and remove with no pain for the patient;
    - is 100% Natural;
    - does not contain active ingredients;
    - did not provoke evidenced allergic reaction;
    - is available in different dimensions and thickness.
    The technology offers the possibility to produce different products, as well as the use of other biopolymers such as collagen or hyaluronic and the whole manufacturing process can be easily transferred to an industrial scale.
    The 3D-printing platform is continuously under development through the creation of highly reproducible, robust and flexible instruments for the controlled modulation of such biopolymers.
  • IPR Status:
    Secret Know-how,Patents granted
  • EOI Status:
    No
  • Experience:

Organisation

  • Type of organisation:
  • Since:
    2016
  • Type and Size:
    Industry SME = 10
  • Transnational
    Nee
  • Turnover:

Collaboration

  • Technical Specification or Expertise Sought:
    pppThe startup is looking for pharmaceutical or biomedical companies partners interested in the development of innovative medical devices in the regenerative medicine field.
    The startup is seeking a manufacturing agreement to support the industrialization process of its products, but it is also open to financial or license agreement.pp251-500,SME 51-250,500p
  • Partnerships
    • License agreement
    • Financial agreement
    • Manufacturing agreement
    • Research cooperation agreement
Uitgevoerd door:
In opdracht van: